Ann: US Defense funds AU$5.5M for Immuron New Gastro Weapon, page-52

Clearly no confidence/trust in Gary Jacob.

Last two positive announcements have resulted in the same reaction from the market, both on the ASX and NASDAQ.

"Great news, But ......" (enabling one to coin the phrase the "Jacob Effect")

Maybe when/if Travelan receives FDA approval, positive market movement may outweigh the negativity/lack of trust in Jacob, allowing for the justified market value of IMC to be realised.

Shame his soon to be realised 5,000,000 Oppies don't have the same expiry date as IMCOB's, may have seen a more concerted effort to raise the share price.